Asthma-COPD Overlap
On this page
Direct answer
Asthma-COPD overlap describes persistent airflow limitation in a patient with features of both asthma and COPD, most often a smoker with early-onset atopy or raised eosinophils. It is suspected when the post-bronchodilator FEV1 to FVC ratio stays below 0.7 alongside several asthma-type features. Treatment usually starts with an inhaled corticosteroid combined with a long-acting bronchodilator, rather than a COPD-only regimen.
What you must remember
- Persistent airflow limitation: a post-bronchodilator FEV1/FVC below 0.7 is the spirometric anchor for the overlap.
- Asthma features: onset before age 40, atopy, a family history of asthma, and variable symptoms including night waking.
- COPD features: smoking exposure above about 10 pack-years, age over 40, and chronic cough or sputum production.
- Eosinophils: raised blood eosinophils, around 300 cells per microlitre or more, predict a response to inhaled corticosteroids.
- Reversibility: a significant bronchodilator response supports an asthma component, although it can be modest in COPD and in overlap.
- Treatment: an inhaled corticosteroid with a long-acting beta agonist is the usual start, with a long-acting muscarinic antagonist added if symptoms persist.
- Indian mimics: biomass smoke exposure, bronchiectasis and tuberculosis must be excluded when the picture is atypical or sputum persists.
Building the overlap diagnosis
Overlap is a label that needs spirometry and a feature count, not a guess from age alone. The steps separate true overlap from simple asthma or simple COPD.
- Confirm airflow limitation: A post-bronchodilator FEV1/FVC below 0.7 establishes persistent airflow limitation, which is needed before the overlap label is applied.
- Score the asthma features: Record early onset, atopy, variable symptoms, bronchodilator response and blood eosinophil count, since several features are needed.
- Score the COPD features: Record smoking history above about 10 pack-years, age over 40, chronic cough or sputum, and any biomass smoke exposure.
- Match the pattern: Overlap is assigned when features of both diseases are present, with the stronger pattern guiding the working label.
- Choose inhaler therapy: An inhaled corticosteroid with a long-acting beta agonist is started, and a long-acting muscarinic antagonist is added if symptoms or exacerbations persist.
- Review and exclude mimics: Repeat spirometry and eosinophil counts, and consider tuberculosis or bronchiectasis when sputum persists or the picture is atypical.
Where the overlap gets missed
Overlap questions often hinge on one feature that the student overlooks, usually the atopy history or the spirometry ratio.
- Trap: labelling every smoker with airflow limitation as pure COPD Correct: early-onset atopy or raised eosinophils are overlap features, and steroid-containing therapy can then help.
- Trap: using FEV1 alone to define airflow limitation Correct: the post-bronchodilator FEV1/FVC ratio below 0.7 is the criterion, because FEV1 alone does not separate obstruction from restriction.
- Trap: assuming persistent sputum in a biomass-exposed woman is simply COPD Correct: tuberculosis and bronchiectasis are common mimics, so investigation should be considered before settling on the diagnosis.
Frequently asked questions
What defines asthma-COPD overlap?
Asthma-COPD overlap is defined by persistent airflow limitation with several features of both asthma and COPD. It is a descriptive label rather than a single disease (current GINA and GOLD reports no longer treat it as a distinct entity), and it guides the choice of inhaler therapy.
Which spirometry result confirms persistent airflow limitation?
A post-bronchodilator FEV1 to FVC ratio below 0.7 confirms persistent airflow limitation, which is needed before asthma-COPD overlap is diagnosed. Without this result, a patient with variable asthma symptoms cannot be placed in the overlap group.
Which features point to an asthma component in a long-term smoker?
Early onset before age 40, atopy, a family history of asthma and a significant bronchodilator response point to an asthma component in a smoker. Raised blood eosinophils also suggest that inhaled corticosteroids will help in asthma-COPD overlap.
Which inhaler is usually started in asthma-COPD overlap?
An inhaled corticosteroid with a long-acting beta agonist is usually started in asthma-COPD overlap, with a long-acting muscarinic antagonist added if symptoms persist. The steroid component addresses the asthma features, while the bronchodilators treat the airflow limitation.